Bausch & Lomb, which develops contact lenses, surgical devices and eye therapies, has filed for an initial public offering. The company looks to obtain as much as $100 million from the offering.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||